CN102348463B - 白介素-22在预防和/或治疗多器官功能障碍综合症(mods)中的用途 - Google Patents
白介素-22在预防和/或治疗多器官功能障碍综合症(mods)中的用途 Download PDFInfo
- Publication number
- CN102348463B CN102348463B CN201080010768.7A CN201080010768A CN102348463B CN 102348463 B CN102348463 B CN 102348463B CN 201080010768 A CN201080010768 A CN 201080010768A CN 102348463 B CN102348463 B CN 102348463B
- Authority
- CN
- China
- Prior art keywords
- multiple organ
- organ dysfunction
- dysfunction syndrome
- treatment
- interleukin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (6)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14413409P | 2009-01-12 | 2009-01-12 | |
US61/144,134 | 2009-01-12 | ||
PCT/US2010/020673 WO2010081112A1 (en) | 2009-01-12 | 2010-01-11 | Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102348463A CN102348463A (zh) | 2012-02-08 |
CN102348463B true CN102348463B (zh) | 2014-05-07 |
Family
ID=42316862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080010768.7A Active CN102348463B (zh) | 2009-01-12 | 2010-01-11 | 白介素-22在预防和/或治疗多器官功能障碍综合症(mods)中的用途 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8956605B2 (zh) |
EP (1) | EP2385841B1 (zh) |
JP (1) | JP5981141B2 (zh) |
CN (1) | CN102348463B (zh) |
AU (1) | AU2010203446B2 (zh) |
CA (1) | CA2748392C (zh) |
WO (1) | WO2010081112A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术(上海)有限公司 | 白介素-22在治疗脂肪肝中的应用 |
TR201809571T4 (tr) | 2013-03-15 | 2018-07-23 | Hoffmann La Roche | Ll-22 polipeptidleri ile ıl-22 fc füzyon proteinleri ve kullanım yöntemleri. |
CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术(上海)有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
WO2017181143A1 (en) | 2016-04-15 | 2017-10-19 | Generon (Shanghai) Corporation, Ltd. | Use of il-22 in treating necrotizing enterocolitis |
CN112007146A (zh) * | 2020-09-03 | 2020-12-01 | 上海市儿童医院 | Il-22在治疗和/或预防脓毒症诱发的肝脏损伤的药物中的用途 |
US20240033232A1 (en) * | 2021-03-10 | 2024-02-01 | Wen Tan | New use of (R)-B2-agonists in treatment of sepsis and acute respiratory distress syndrome |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070207943A1 (en) * | 1998-05-29 | 2007-09-06 | Human Genome Sciences, Inc. | Interleukins-21 and 22 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010023070A1 (en) * | 1998-05-29 | 2001-09-20 | Reinhard Ebner | Interleukins-21 and 22 |
US7226591B2 (en) * | 2000-05-22 | 2007-06-05 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
CN100515491C (zh) * | 2005-01-04 | 2009-07-22 | 健能隆医药技术(上海)有限公司 | 白介素-22的医药用途 |
CN101219208B (zh) * | 2005-01-04 | 2010-08-11 | 健能隆医药技术(上海)有限公司 | 白介素-22的医药用途 |
US20080031882A1 (en) * | 2006-06-19 | 2008-02-07 | Liang Spencer C | Methods of modulating IL-22 and IL-17 |
WO2008085229A2 (en) * | 2006-11-15 | 2008-07-17 | Arteriocyte Inc. | Cell-based therapies for treating liver disease |
CN101168049A (zh) * | 2007-10-23 | 2008-04-30 | 中国人民解放军军事医学科学院基础医学研究所 | 白介素-22在制备治疗肝病药物中的应用及其制备方法 |
-
2010
- 2010-01-11 US US13/142,423 patent/US8956605B2/en active Active
- 2010-01-11 CN CN201080010768.7A patent/CN102348463B/zh active Active
- 2010-01-11 JP JP2011545498A patent/JP5981141B2/ja active Active
- 2010-01-11 CA CA2748392A patent/CA2748392C/en active Active
- 2010-01-11 WO PCT/US2010/020673 patent/WO2010081112A1/en active Application Filing
- 2010-01-11 AU AU2010203446A patent/AU2010203446B2/en active Active
- 2010-01-11 EP EP10729641.0A patent/EP2385841B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070207943A1 (en) * | 1998-05-29 | 2007-09-06 | Human Genome Sciences, Inc. | Interleukins-21 and 22 |
Non-Patent Citations (2)
Title |
---|
多器官功能障碍综合征的进展;甘枚 等;《医学综述》;20060731;第12卷(第14期);862-865 * |
甘枚 等.多器官功能障碍综合征的进展.《医学综述》.2006,第12卷(第14期),862-865. |
Also Published As
Publication number | Publication date |
---|---|
AU2010203446B2 (en) | 2015-12-17 |
CA2748392A1 (en) | 2010-07-15 |
EP2385841A4 (en) | 2012-12-19 |
CA2748392C (en) | 2017-06-27 |
WO2010081112A1 (en) | 2010-07-15 |
AU2010203446A1 (en) | 2011-07-14 |
EP2385841B1 (en) | 2016-11-16 |
CN102348463A (zh) | 2012-02-08 |
US8956605B2 (en) | 2015-02-17 |
US20110268696A1 (en) | 2011-11-03 |
EP2385841A1 (en) | 2011-11-16 |
JP5981141B2 (ja) | 2016-08-31 |
JP2012515165A (ja) | 2012-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102348463B (zh) | 白介素-22在预防和/或治疗多器官功能障碍综合症(mods)中的用途 | |
HU230160B1 (hu) | Interleukin-I inhibitort és kontrollált felszabadulású polimerként hialuronant tartalmazó készítmények | |
JP2005537234A5 (zh) | ||
WO2015110002A1 (zh) | 人白细胞介素ⅱ突变体及其应用 | |
AU2018214160B2 (en) | Novel peptides and analogs for use in the treatment of oral mucositis | |
EP0433765A1 (en) | The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy | |
US20050271726A1 (en) | Immune enhancing compositions and methods of use thereof | |
US8877203B2 (en) | Composition and method for preventing and treating immune-related disorder | |
WO2019171352A3 (en) | Methods of treating severe non-diabetic obesity | |
WO2003084979A3 (fr) | Peptides et leur application en therapeutique | |
US9149514B2 (en) | Composition and method for treating papilloma virus and equine sarcoids | |
CN113508126A (zh) | 新型肽及其用途 | |
CN113318222B (zh) | 超氧化物歧化酶在制备治疗银屑病药物中的应用及方法 | |
Finocchiaro et al. | Cytokine-enhanced vaccine and suicide gene therapy as adjuvant treatments of metastatic melanoma in a horse | |
KR20060013515A (ko) | 알파 티모신 펩티드에 의한 호흡기 바이러스 감염 치료또는 예방 | |
WO2007041964A1 (fr) | Utilisation de recepteur long du facteur de necrose tumorale alpha soluble recombinant humain de demi-vie dans la preparation de medicament pouvant prevenir l'insuffisance hepatique | |
CA2574477C (en) | Alpha-defensins as anthrax immunotherapeutics | |
JP2002529515A5 (zh) | ||
JP2019524089A5 (zh) | ||
Chow et al. | Stability assessment and formulation characterization | |
JPS62252729A (ja) | 造血機能回復促進剤 | |
CN1657097A (zh) | 转移因子抗艾滋病毒的作用 | |
JP2020524132A5 (zh) | ||
WO2021239165A3 (es) | Péptido para el tratamiento de infecciones originadas por coronavirus | |
Deepe | Vaccines for histoplasmosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 Effective date of registration: 20140617 Granted publication date: 20140507 Pledgee: Pudong Shanghai technology financing Company limited by guarantee Pledgor: Generon (Shanghai) Corporation Ltd. Registration number: 2014310000038 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201203 Room 302 / 303, building 9, Lane 1011, Halley Road, Zhangjiang hi tech, Pudong New Area, Shanghai Patentee after: Yiyi biomedical development (Shanghai) Co.,Ltd. Address before: 201203 Room 302 / 303, building 9, Lane 1011, Halley Road, Zhangjiang hi tech, Pudong New Area, Shanghai Patentee before: GENERON (SHANGHAI) Corp.,Ltd. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210628 Granted publication date: 20140507 Pledgee: Pudong Shanghai technology financing Company limited by guarantee Pledgor: GENERON (SHANGHAI) Corp.,Ltd. Registration number: 2014310000038 |